NCT06771921 2026-01-30
A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors
Genmab
Phase 1/2 Terminated
Clinical Trials
9 trialsNCT06391775 2025-12-26
Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy
Genmab
Phase 1/2 Terminated
NCT06735144 2025-12-05
Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Recruiting
NCT04632108 2025-09-11
A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Phase 1/2 Active not recruiting
NCT07136142 2025-08-22
A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Not yet recruiting
NCT01309490 2025-07-29
Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients
Jewish General Hospital
Phase 1/2 Terminated
NCT04571892 2023-04-12
A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors
Shanghai East Hospital
Phase 1/2 Unknown
NCT02754141 2023-04-05
An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab
Bristol-Myers Squibb
Phase 1/2 Completed
NCT03551795 2022-05-09
Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor
Shanghai Public Health Clinical Center
Phase 1/2 Completed